Nurofen manufacturer fined $1.7m for misleading customers
by Calla Wahlquist from on (#1C5MJ)
Reckitt Benckiser says it did not intentionally mislead about tablets targeting different types of pain
Related: Nurofen maker deserves $6m fine for false claims, court told
Nurofen manufacturer Reckitt Benckiser has been fined $1.7m for misleading customers about its range of specific pain products, which were marketed as targeting different types of pain despite containing the same active ingredient.
Continue reading...